[1] |
Hao Mingxiao, Mi Jie, Xu Zongyi.
Effectiveness of a continuity of care model in patients with tuberculous meningitis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
|
[2] |
Wang Xueyu, Wang Yujin, Chu Naihui, Kang Wanli, Nie Wenjuan.
A preliminary study on the enhanced in vivo exposure of sudapyridine in Mycobacterium abscessus-infected rats with the co-administration of clofazimine or clarithromycin
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 150-157.
|
[3] |
Li Yang, Sun Feng, Zhang Wenhong.
Short-course treatment for tuberculosis: past achievements and future directions
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 991-997.
|
[4] |
Chai Dongyu, Qin Shuyi, Zhang Ronghua, Zou Nannan, Wang Xin.
Analysis of risk factors for viral pneumonia combined with invasive pulmonary mycosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 750-755.
|
[5] |
Zhang Hui, Ge Li, Zhang Yuhan, Feng Ruie.
Clinicopathologic characteristics of 34 cases non-tuberculous mycobacterial disease
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 756-762.
|
[6] |
Yang Chengqing, Chen Shufang, Mei Chunlin, Cao Tanze, Feng Wei, Liu Xiuping, Xu Wenjing, Du Ronghui.
Clinical characteristics of 220 cases of pulmonary tuberculosis combined with chronic pulmonary aspergillosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 770-777.
|
[7] |
Li Jianghong, Liu Fang, Yang Shumin, He Yujue, Ma Ling, Guo Qiang, Man Shijun.
Investigation and analysis of diagnostic quality of pathogenic negative pulmonary tuberculosis in county level tuberculosis designated hospitals in Gansu Province
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1478-1484.
|
[8] |
Wang Xueyu, Shi Wenhui, Li Qi, Jing Wei, Chu Naihui, Nie Wenjuan.
Efficacy and safety of Baidiziyin Pill and Shenqiyifei Pill in adjuvant treatment of susceptible pulmonary tuberculosis patients: a national randomized controlled multicenter clinical study
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1306-1312.
|
[9] |
Nie Wenjuan, Sun Feng, Wang Xueyu, Ren Yanfei, Liu Renyu, Li Minhan, Li Qi, Zhang Wenhong, Chu Naihui.
Multi center randomized controlled clinical trial of shorter oral regimen containing new drugs in the treatment of rifampicin-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1313-1319.
|
[10] |
Fu Liang, Deng Guofang.
MDR-Chin study analysis: prospects of using all-oral short-course treatment regimens for multidrug-resistant pulmonary tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 18-22.
|
[11] |
Liu Qiliang, Li Yuejie, Lei Mei.
Clinicopathological features of 13 cases cervical lymph node tuberculosis complicated with metastatic carcinoma
[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 891-896.
|
[12] |
Zhao Guolian, Lei Qian, Wang Pei, Ren Yunxia, Guan Jing.
Value of DNA real-time fluorescence isothermal amplification method and combined testing in early diagnosis of tuberculous pleurisy
[J]. Chinese Journal of Antituberculosis, 2023, 45(7): 681-686.
|
[13] |
Li Hongna, Mao Xin, Xu Biyu, Wu Chenyang, Dong Liru, Song Xudong.
Clinical value of common in situ pathological staining in diagnosis of pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(5): 477-482.
|
[14] |
Zhou Feng, Li Tongxin, Yang Song, Tang Shenjie.
Progress on short-course regimens for the treatment of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(3): 311-317.
|
[15] |
Tian Lili, Chen Shuangshuang, Fan Ruifang, Zhang Jie, Wang Nenhan, Chen Hao, Dai Xiaowei, Ren Yixuan, Zhao Yanfeng, Li Chuanyou, Ding Beichuan, Li Bo, Yu Lan, Yi Junli, Wang Pei, Yang Xinyu, Song Weiping.
Clinical diagnostic value of combining four methods in detecting etiologically negative pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 144-150.
|